Discovery Clinical Trials is categorized under Business Services (Unclassified) in Kissimmee, FL and active since 2013.
Discovery Clinical Trials was established in 2013, and today employs 1 to 4, earning Unknown per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 410 Celebration Place # 203, Kissimmee, Florida FL 34747 or by phoning (407) 964-3180. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Discovery Clinical Trials |
| Address: | 410 Celebration Place # 203, Kissimmee, Florida 34747 |
| Phone Number: | (407) 964-3180 |
| Website Address: | discoveryclinicaltrials.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Services (Unclassified) |
| SIC Code: | 7389 |
| NAICS Code: | 561499 |
| Share This Business: |
Discovery Clinical Trials was started in 2013 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact for inquiries that concern Discovery Clinical Trials by calling the company number (407) 964-3180, as your correspondence is most welcome. Additionally, the physical location of the single location of Discovery Clinical Trials can be found at the coordinates 28.32979,-81.53922 as well as the street address 410 Celebration Place # 203 in Kissimmee, Florida 34747.
For its online presence, you may visit Discovery Clinical Trials’s website at discoveryclinicaltrials.com and engage with its social media outlets through on Twitter and on Facebook.